Doctors Ponder FDA Drug Controversy
15218
Startling testimony by an FDA drug safety reviewer about five popular medications has the medical world buzzing about how tightly the agency should be regulating new medications.
88844
Across the United States, doctors are struggling to decide which pain relievers to prescribe now that they know that popular drugs like Vioxx and Celebrex pose potentially serious heart risks.
697522
If its latest drug isn't approved, the pharmaceutical could face trouble.
287777
Federal regulators Thursday urged doctors to think twice before prescribing several popular and controversial painkillers to their patients with histories of heart trouble.
137276
ROCKVILLE, Md.  - The U.S. Food and Drug  Administration on Friday asked an outside group to review the  way the agency monitors safety risks of medicines after they  hit the market, such as Merck & Co. Inc.'s withdrawn painkiller  Vioxx.
289430
DOCTORS should ask if patients take alternative medicines after a study found alternative medicines could complicate treatment in hospital and emergency departments.
32784
The panel is examining claims that GlaxoSmithKline tried to suppress a doctorâs criticism of its drug Avandia.
236669
With yet more already-marketed medicines raising the ire of consumer advocates and regulators alike, momentum is building for reform of the governmentâs drug approval and monitoring procedures.
268363
GAITHERSBURG, Maryland  - The Food and Drug Administration should consider telling patients and doctors that the use of drug-coated heart stents in unapproved, high-risk cases can lead to greater complications, a panel of medical experts said on Friday.
8068
Drug makers are exploring the possibility of tying pharmaceutical prices to performance.
226044
U.S. health officials said on Friday  they would review whether to take regulatory action over Merck  & Co Inc  and Schering-Plough's  cholesterol  medicine Vytorin following the drug's failure to work better  than a generic drug in a study of plaque build-up in neck  arteries.
386658
The U.S. Food and Drug Administration is facing new questions about its ability to police the safety of medicines after they reach the market following concerns about a widely used diabetes drug.
586727
Consumer advocates backed by some  prominent doctors and researchers on Thursday questioned a new  U.S. policy recommending wider use of statin drugs to lower  cholesterol.
41829
The Food and Drug Administration of the US found itself in the midst of a rather unpleasant controversy. Recently the chief of Cleveland Clinic Foundationâs department of cardiovascular medicine blamed this
137436
A panel is examining claims that GlaxoSmithKline tried to suppress a doctorâs criticism of its drug Avandia.
513761
The U.S. Food and Drug Administration on Friday asked an outside group to review the way it monitors safety risks associated with medicines already on the market, such as Merck & Co. Inc.'s withdrawn painkiller Vioxx.
217268
Federal regulators urged doctors Thursday to think twice before prescribing several popular but controversial painkillers for patients with histories of heart trouble.